Extended ASCOT - lipid lowering (ASCOT-LLA) study shows positive results of atorvastatin.
D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000009:adverse effects; D000069059:Atorvastatin; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000188:drug therapy*; D005500:Follow-Up Studies; D006538:Heptanoic Acids / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D015994:Incidence; D050356:Lipid Metabolism / Q000187:drug effects; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D011758:Pyrroles / Q000008:administration & dosage / Q000009:adverse effects; D020521:Stroke / Q000188:drug therapy; D016896:Treatment Outcome; D028761:Withholding Treatment
D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin